AdvanceAD-Tx Predicts JAK Response in Dermatitis
FRIENDSWOOD, Texas, Feb. 19, 2026 — Castle Biosciences announced prospective clinical validation data published in the Journal of the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
FRIENDSWOOD, Texas, Feb. 19, 2026 — Castle Biosciences announced prospective clinical validation data published in the Journal of the...
SALT LAKE CITY, December 29, 2025 — Co-Diagnostics announced that the Australian Patent Office has granted a key patent...
United States | December 23, 2025 — Fulgent Genetics has entered into a definitive agreement to acquire specific assets...
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2025 — CareDx, Inc., a leader in precision medicine for transplant patients, announced...
Dateline — SALT LAKE CITY, November 11, 2025:Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostic testing...
Stockholm — October 6, 2025. The Nobel Assembly at Karolinska Institutet has awarded the 2025 Nobel Prize in Physiology...
WEST HILLS, Calif., Oct. 8, 2025 — Thermo Fisher Scientific has introduced the Molecular Microscope® Diagnostic System for Lung...
CINCINNATI, OHIO, September 16, 2025 – Meridian Bioscience, Inc., a global leader in diagnostics and life science raw materials,...
